nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—uterine cancer—fallopian tube cancer	0.495	0.558	CtDrD
Doxorubicin—ovarian cancer—fallopian tube cancer	0.393	0.442	CtDrD
Doxorubicin—SLC22A16—female reproductive system—fallopian tube cancer	0.00249	0.0223	CbGeAlD
Doxorubicin—CBR3—uterine cervix—fallopian tube cancer	0.00249	0.0223	CbGeAlD
Doxorubicin—CBR3—endometrium—fallopian tube cancer	0.00225	0.0201	CbGeAlD
Doxorubicin—ABCB8—female reproductive system—fallopian tube cancer	0.00194	0.0173	CbGeAlD
Doxorubicin—AKR1A1—uterine cervix—fallopian tube cancer	0.00192	0.0172	CbGeAlD
Doxorubicin—CBR3—female reproductive system—fallopian tube cancer	0.00187	0.0167	CbGeAlD
Doxorubicin—ABCB8—female gonad—fallopian tube cancer	0.00177	0.0158	CbGeAlD
Doxorubicin—NDUFS7—uterine cervix—fallopian tube cancer	0.00175	0.0156	CbGeAlD
Doxorubicin—AKR1A1—endometrium—fallopian tube cancer	0.00174	0.0156	CbGeAlD
Doxorubicin—CBR3—female gonad—fallopian tube cancer	0.0017	0.0152	CbGeAlD
Doxorubicin—CBR3—vagina—fallopian tube cancer	0.00169	0.0151	CbGeAlD
Doxorubicin—AURKA—uterine cervix—fallopian tube cancer	0.00163	0.0145	CbGeAlD
Doxorubicin—AKR1A1—uterus—fallopian tube cancer	0.0016	0.0143	CbGeAlD
Doxorubicin—NOS1—epithelium—fallopian tube cancer	0.00147	0.0131	CbGeAlD
Doxorubicin—AURKA—endometrium—fallopian tube cancer	0.00147	0.0131	CbGeAlD
Doxorubicin—NDUFS2—uterine cervix—fallopian tube cancer	0.00145	0.013	CbGeAlD
Doxorubicin—AKR1A1—female reproductive system—fallopian tube cancer	0.00144	0.0129	CbGeAlD
Doxorubicin—NDUFS3—uterine cervix—fallopian tube cancer	0.00143	0.0128	CbGeAlD
Doxorubicin—DHCR7—uterine cervix—fallopian tube cancer	0.00136	0.0122	CbGeAlD
Doxorubicin—AURKA—uterus—fallopian tube cancer	0.00136	0.0121	CbGeAlD
Doxorubicin—AKR1A1—female gonad—fallopian tube cancer	0.00131	0.0117	CbGeAlD
Doxorubicin—NDUFS2—endometrium—fallopian tube cancer	0.00131	0.0117	CbGeAlD
Doxorubicin—NDUFS7—female reproductive system—fallopian tube cancer	0.00131	0.0117	CbGeAlD
Doxorubicin—AKR1A1—vagina—fallopian tube cancer	0.0013	0.0117	CbGeAlD
Doxorubicin—NDUFS3—endometrium—fallopian tube cancer	0.00129	0.0116	CbGeAlD
Doxorubicin—YWHAG—uterine cervix—fallopian tube cancer	0.00125	0.0112	CbGeAlD
Doxorubicin—AURKA—female reproductive system—fallopian tube cancer	0.00122	0.0109	CbGeAlD
Doxorubicin—XDH—uterine cervix—fallopian tube cancer	0.00122	0.0109	CbGeAlD
Doxorubicin—NDUFS2—uterus—fallopian tube cancer	0.00121	0.0108	CbGeAlD
Doxorubicin—NDUFS3—uterus—fallopian tube cancer	0.00119	0.0107	CbGeAlD
Doxorubicin—NDUFS7—female gonad—fallopian tube cancer	0.00119	0.0107	CbGeAlD
Doxorubicin—NDUFS7—vagina—fallopian tube cancer	0.00119	0.0106	CbGeAlD
Doxorubicin—YWHAG—endometrium—fallopian tube cancer	0.00113	0.0101	CbGeAlD
Doxorubicin—RALBP1—uterine cervix—fallopian tube cancer	0.00113	0.0101	CbGeAlD
Doxorubicin—NOS3—epithelium—fallopian tube cancer	0.00112	0.00999	CbGeAlD
Doxorubicin—AURKA—female gonad—fallopian tube cancer	0.00111	0.00991	CbGeAlD
Doxorubicin—AURKA—vagina—fallopian tube cancer	0.0011	0.00985	CbGeAlD
Doxorubicin—XDH—endometrium—fallopian tube cancer	0.0011	0.00984	CbGeAlD
Doxorubicin—NOS1—female reproductive system—fallopian tube cancer	0.00109	0.00977	CbGeAlD
Doxorubicin—NDUFS2—female reproductive system—fallopian tube cancer	0.00109	0.0097	CbGeAlD
Doxorubicin—NDUFS3—female reproductive system—fallopian tube cancer	0.00107	0.00959	CbGeAlD
Doxorubicin—CBR1—uterine cervix—fallopian tube cancer	0.00105	0.0094	CbGeAlD
Doxorubicin—YWHAG—uterus—fallopian tube cancer	0.00104	0.0093	CbGeAlD
Doxorubicin—AKR1C3—uterine cervix—fallopian tube cancer	0.00104	0.00929	CbGeAlD
Doxorubicin—RALBP1—endometrium—fallopian tube cancer	0.00102	0.00911	CbGeAlD
Doxorubicin—DHCR7—female reproductive system—fallopian tube cancer	0.00102	0.00911	CbGeAlD
Doxorubicin—NDUFS2—female gonad—fallopian tube cancer	0.000988	0.00883	CbGeAlD
Doxorubicin—NDUFS2—vagina—fallopian tube cancer	0.000982	0.00878	CbGeAlD
Doxorubicin—NDUFS3—female gonad—fallopian tube cancer	0.000976	0.00872	CbGeAlD
Doxorubicin—NDUFS3—vagina—fallopian tube cancer	0.00097	0.00867	CbGeAlD
Doxorubicin—CBR1—endometrium—fallopian tube cancer	0.000952	0.0085	CbGeAlD
Doxorubicin—POR—uterine cervix—fallopian tube cancer	0.000949	0.00848	CbGeAlD
Doxorubicin—AKR1C3—endometrium—fallopian tube cancer	0.00094	0.0084	CbGeAlD
Doxorubicin—RALBP1—uterus—fallopian tube cancer	0.000939	0.00839	CbGeAlD
Doxorubicin—YWHAG—female reproductive system—fallopian tube cancer	0.000935	0.00836	CbGeAlD
Doxorubicin—DHCR7—female gonad—fallopian tube cancer	0.000927	0.00829	CbGeAlD
Doxorubicin—DHCR7—vagina—fallopian tube cancer	0.000922	0.00824	CbGeAlD
Doxorubicin—XDH—female reproductive system—fallopian tube cancer	0.000912	0.00815	CbGeAlD
Doxorubicin—TOP2A—uterine cervix—fallopian tube cancer	0.000884	0.0079	CbGeAlD
Doxorubicin—CBR1—uterus—fallopian tube cancer	0.000877	0.00784	CbGeAlD
Doxorubicin—AKR1C3—uterus—fallopian tube cancer	0.000866	0.00774	CbGeAlD
Doxorubicin—POR—endometrium—fallopian tube cancer	0.000858	0.00767	CbGeAlD
Doxorubicin—YWHAG—female gonad—fallopian tube cancer	0.000851	0.0076	CbGeAlD
Doxorubicin—NQO1—epithelium—fallopian tube cancer	0.00085	0.0076	CbGeAlD
Doxorubicin—YWHAG—vagina—fallopian tube cancer	0.000846	0.00756	CbGeAlD
Doxorubicin—RALBP1—female reproductive system—fallopian tube cancer	0.000844	0.00755	CbGeAlD
Doxorubicin—NQO1—uterine cervix—fallopian tube cancer	0.000843	0.00753	CbGeAlD
Doxorubicin—NOS3—female reproductive system—fallopian tube cancer	0.000831	0.00742	CbGeAlD
Doxorubicin—XDH—vagina—fallopian tube cancer	0.000825	0.00737	CbGeAlD
Doxorubicin—TOP2A—endometrium—fallopian tube cancer	0.0008	0.00715	CbGeAlD
Doxorubicin—CBR1—female reproductive system—fallopian tube cancer	0.000788	0.00705	CbGeAlD
Doxorubicin—RALBP1—female gonad—fallopian tube cancer	0.000768	0.00687	CbGeAlD
Doxorubicin—RALBP1—vagina—fallopian tube cancer	0.000764	0.00683	CbGeAlD
Doxorubicin—NQO1—endometrium—fallopian tube cancer	0.000762	0.00681	CbGeAlD
Doxorubicin—ABCC10—uterine cervix—fallopian tube cancer	0.000753	0.00673	CbGeAlD
Doxorubicin—NOS3—vagina—fallopian tube cancer	0.000751	0.00671	CbGeAlD
Doxorubicin—TOP2A—uterus—fallopian tube cancer	0.000737	0.00659	CbGeAlD
Doxorubicin—CBR1—female gonad—fallopian tube cancer	0.000717	0.00641	CbGeAlD
Doxorubicin—CBR1—vagina—fallopian tube cancer	0.000713	0.00637	CbGeAlD
Doxorubicin—AKR1C3—female gonad—fallopian tube cancer	0.000708	0.00633	CbGeAlD
Doxorubicin—AKR1C3—vagina—fallopian tube cancer	0.000704	0.00629	CbGeAlD
Doxorubicin—NQO1—uterus—fallopian tube cancer	0.000703	0.00628	CbGeAlD
Doxorubicin—ABCC10—endometrium—fallopian tube cancer	0.000681	0.00609	CbGeAlD
Doxorubicin—POR—female gonad—fallopian tube cancer	0.000647	0.00578	CbGeAlD
Doxorubicin—POR—vagina—fallopian tube cancer	0.000643	0.00575	CbGeAlD
Doxorubicin—NQO1—female reproductive system—fallopian tube cancer	0.000632	0.00564	CbGeAlD
Doxorubicin—ABCC10—uterus—fallopian tube cancer	0.000628	0.00561	CbGeAlD
Doxorubicin—TOP2A—female gonad—fallopian tube cancer	0.000603	0.00539	CbGeAlD
Doxorubicin—TOP2A—vagina—fallopian tube cancer	0.000599	0.00536	CbGeAlD
Doxorubicin—NQO1—female gonad—fallopian tube cancer	0.000575	0.00514	CbGeAlD
Doxorubicin—NQO1—vagina—fallopian tube cancer	0.000571	0.00511	CbGeAlD
Doxorubicin—ABCC3—female reproductive system—fallopian tube cancer	0.000567	0.00507	CbGeAlD
Doxorubicin—ABCC10—female reproductive system—fallopian tube cancer	0.000564	0.00504	CbGeAlD
Doxorubicin—ABCC1—uterine cervix—fallopian tube cancer	0.000533	0.00476	CbGeAlD
Doxorubicin—ABCC3—female gonad—fallopian tube cancer	0.000516	0.00461	CbGeAlD
Doxorubicin—ABCC10—female gonad—fallopian tube cancer	0.000513	0.00459	CbGeAlD
Doxorubicin—ABCC10—vagina—fallopian tube cancer	0.00051	0.00456	CbGeAlD
Doxorubicin—CYP1B1—uterus—fallopian tube cancer	0.000493	0.00441	CbGeAlD
Doxorubicin—ABCC1—endometrium—fallopian tube cancer	0.000482	0.0043	CbGeAlD
Doxorubicin—ABCC2—female reproductive system—fallopian tube cancer	0.000453	0.00405	CbGeAlD
Doxorubicin—ABCC1—uterus—fallopian tube cancer	0.000444	0.00397	CbGeAlD
Doxorubicin—CYP1B1—female reproductive system—fallopian tube cancer	0.000444	0.00396	CbGeAlD
Doxorubicin—ABCG2—uterine cervix—fallopian tube cancer	0.000441	0.00394	CbGeAlD
Doxorubicin—CYP1B1—female gonad—fallopian tube cancer	0.000404	0.00361	CbGeAlD
Doxorubicin—ABCG2—endometrium—fallopian tube cancer	0.000399	0.00356	CbGeAlD
Doxorubicin—ABCG2—uterus—fallopian tube cancer	0.000367	0.00328	CbGeAlD
Doxorubicin—ABCC1—female gonad—fallopian tube cancer	0.000363	0.00324	CbGeAlD
Doxorubicin—ABCC1—vagina—fallopian tube cancer	0.000361	0.00322	CbGeAlD
Doxorubicin—CYP2B6—female reproductive system—fallopian tube cancer	0.000305	0.00272	CbGeAlD
Doxorubicin—ABCG2—female gonad—fallopian tube cancer	0.000301	0.00269	CbGeAlD
Doxorubicin—ABCG2—vagina—fallopian tube cancer	0.000299	0.00267	CbGeAlD
Doxorubicin—CYP2B6—vagina—fallopian tube cancer	0.000276	0.00246	CbGeAlD
Doxorubicin—CYP3A4—female reproductive system—fallopian tube cancer	0.00023	0.00206	CbGeAlD
Doxorubicin—CYP2D6—female reproductive system—fallopian tube cancer	0.000226	0.00202	CbGeAlD
Doxorubicin—ABCB1—epithelium—fallopian tube cancer	0.000219	0.00196	CbGeAlD
Doxorubicin—ABCB1—uterine cervix—fallopian tube cancer	0.000217	0.00194	CbGeAlD
Doxorubicin—CYP2D6—female gonad—fallopian tube cancer	0.000206	0.00184	CbGeAlD
Doxorubicin—ABCB1—endometrium—fallopian tube cancer	0.000197	0.00176	CbGeAlD
Doxorubicin—ABCB1—uterus—fallopian tube cancer	0.000181	0.00162	CbGeAlD
Doxorubicin—ABCB1—female reproductive system—fallopian tube cancer	0.000163	0.00146	CbGeAlD
Doxorubicin—ABCB1—female gonad—fallopian tube cancer	0.000148	0.00132	CbGeAlD
Doxorubicin—ABCB1—vagina—fallopian tube cancer	0.000147	0.00132	CbGeAlD
